FINANCIALS

ANAB Anaptysbio Inc 1370053

Income Statement
Revenue	anab-20241231	91,280,000
Net Income	anab-20241231	-145,231,000
Profit Margin		-159.1%

Balance Sheet
Current Assets	431,876,000
Assets	483,834,000
Current Liabilities	45,428,000
Liabilities	412,966,000
Equity	70,868,000
Shares Out	30,200,000

Cash Flow Statement
Operating Cash Flow	-135,337,000
Investing Cash Flow	95,398,000

Market Analysis
Market Cap	1,148,309,672
Price	16.80
BVPS	2.35
PB	6.76
EPS	-6.34
PS	3.15
FCF	-39,939,000

Dividends

Earnings

Find a discrepancy? The most accurate way to find company fundamental data is to view ANAB documents filed with the SEC.

ANAB Filings Clear

View A List of Tickers